SCHEMBL30775427

SCHEMBL30775427

c1ccc(-c2cc(OC3CCNC3)ncn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NAE1 Q13564 1/20 0.46
UBA3 Q8TBC4 1/20 0.46
HTR2C P28335 1/20 0.42
HTR2B P41595 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNA4 P43681 1/20 0.42
SYK P43405 1/20 0.41
HRH1 P35367 2/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 1/20 0.41
KCNH2 Q12809 1/20 0.41
HTR1A P08908 1/20 0.40
MKNK1 Q9BUB5 1/20 0.40
MIF P14174 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2264859 0.75 CHRNB2 (0.53) HTR2CHTR2BCHRNB2CHRNA4HRH1
SCHEMBL2269304 0.75 CHRNB2 (0.53) HTR2CHTR2BCHRNB2CHRNA4HRH1
SCHEMBL3655274 0.75 CHRNB2 (0.53) HTR2CHTR2BCHRNB2CHRNA4HRH1
SCHEMBL29994416 0.75 CHRNB2 (0.53) HTR2CHTR2BCHRNB2CHRNA4HRH1
SCHEMBL31234233 0.75 CHRNB2 (0.53) HTR2CHTR2BCHRNB2CHRNA4HRH1
SCHEMBL7464016 0.75 PAICS (0.48) CHRNB2CHRNA4SYKHRH1MKNK1
Hydrochloric Acid SCHEMBL31656540 0.74 CHRNB2 (0.51) HTR2CHTR2BCHRNB2CHRNA4HRH1
Hydrochloric Acid SCHEMBL28668620 0.74 CHRNB2 (0.51) HTR2CHTR2BCHRNB2CHRNA4HRH1
Hydrochloric Acid SCHEMBL22031566 0.74 CHRNB2 (0.51) HTR2CHTR2BCHRNB2CHRNA4HRH1
Hydrochloric Acid SCHEMBL1953011 0.74 CHRNB2 (0.51) HTR2CHTR2BCHRNB2CHRNA4HRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof DONG-A ST CO., LTD. (KR) 2025-03-04 US disclosed
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF DONG-A ST CO., LTD. (KR) 2024-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12240836-B2 Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof EIF2AK4, GCN1, GCGR NPC1 89/4885CYP1A2 1905/4885CYP2C9 1949/4885
US-20240025884-A1 COMPOUNDS AS GCN2 INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF EIF2AK4, GCN1, GCGR NPC1 89/4885CYP1A2 1905/4885CYP2C9 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.